This content is machine translated Myelofibrosis Treatment in transition With the introduction of the Janus kinase (JAK) inhibitor ruxolitinib, therapy for myelofibrosis has changed dramatically in recent years. Nevertheless, further innovation is needed, especially in the second line. Promising…
View Post 5 min This content is machine translated Germ cell tumors of the testis Management of early stages: State of the art Although testicular cancer accounts for only 1% of oncologic disease in men, it is the most common cancer in boys. PD Dr. med. Richard Cathomas, Deputy Chief Physician at the…
View Post 6 min This content is machine translated Non-melanocytic skin tumors Classify basaliomas according to guidelines and treat them in a patient-adapted manner Incidence rates of white skin cancer are increasing and timely diagnosis increases the chances of successful treatment. The current s2k guidelines define criteria for grading tumors at high vs. low…
View Post 3 min This content is machine translated Breast Cancer News from the world of HER2-targeted treatment options Breast carcinoma is the most common malignant tumor in women. The prognosis of patients is determined primarily by the stage and biology of the disease. Innovative therapeutics and new treatment…
View Post 3 min This content is machine translated Advanced stage malignant melanoma Advanced stage malignant melanoma The use of targeted oncologics and immunotherapeutics has revolutionized the treatment of black skin cancer in recent years. However, the optimal therapeutic sequence remains unclear even today. A study analysis…
View Post 10 min This content is machine translated Visceral Surgery Update - Part 1 Upper gastrointestinal tract and COVID-19 complications. Approximately 60 per 1000 population undergo abdominal surgery annually. The majority of patients are initially evaluated and triaged in the primary care physician’s office. Visceral surgery is also constantly evolving,…
View Post 7 min This content is machine translated Gastrointestinal stromal tumors Portrait of a multifaceted disease With the introduction of the new active ingredient avapritinib for the targeted treatment of gastrointestinal stromal tumors into the German market, this clinical picture is once again coming more into…
View Post 4 min This content is machine translated Prognosis of chronic lymphocytic leukemia Coffee grounds and crystal ball of science Valid prognostic and especially predictive markers can play a crucial role in the treatment of cancer. With the development of new therapeutic options for the treatment of chronic lymphocytic leukemia…
View Post 6 min This content is machine translated Platinum-sensitive ovarian cancer PARP inhibitors in the relapsed setting. Ovarian cancer is often not detected until an advanced stage due to initial nonspecific or absent symptoms [1]. Consequently, the prognosis is rather poor, also due to the high relapse…
View Post 3 min This content is machine translated Tumor Profiler Study Detailed profile of tumors In a study involving patients at the University Hospitals of Zurich and Basel, researchers are comprehensively and extremely precisely investigating the molecular and functional characteristics of tumors. This should enable…
View Post 5 min This content is machine translated Orphan disease in oncology Rare is also (cumulatively) common About 7% of the population suffers from a rare disease, in Switzerland. Many of the more than 7000 known orphan diseases are in the oncology field, and more than 40%…
